Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine
University of Wisconsin, Madison
University of Iowa Interventional Psychiatry Service Patient Registry
Mark Niciu
Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair
University of Crete
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
University of Oklahoma
Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation
Naveen Poonai
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
National Institute of Mental Health (NIMH)
Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
Göteborg University
Premedication for Less Invasive Surfactant Administration
University of Oulu
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
University Hospital, Basel, Switzerland
Anesthetics and Analgesics in Children
Chi Dang Hornik
Measuring Analgesic Interventions
Julia Finkel
Ketamine Enhances Analgesia and Mood in Chronic Pain Patients
Salem Anaesthesia Pain Clinic
Dexmedetomidine and Ketamine in VATS Surgery
Ciusss de L'Est de l'Île de Montréal
ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression
University of Saskatchewan
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
National Institute of Mental Health (NIMH)
The Neurobiological Effect of 5-HT2AR Modulation
Gitte Moos Knudsen
Neurobiology of Suicide
National Institute of Mental Health (NIMH)
Ketamine Alcohol (in Treatment-Resistant Depression)
Mark Niciu
National Pregnancy Registry for Psychiatric Medications
Massachusetts General Hospital
Safety Profile of Psilocybin for Cocaine Use Disorder
University of California, Los Angeles
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
Global Coalition for Adaptive Research
Ketamine HCl Prolonged Release Oral Tablets for CRPS
University of Southern California
Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)
University of Wisconsin, Madison
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
University of Utah
Ketamine for Sedation in Severe Traumatic Brain Injury
Henry M. Jackson Foundation for the Advancement of Military Medicine
An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
Nova Mentis Life Science Corp
Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment
University of Pittsburgh
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
PharmaTher Inc.
IM Ketamine vs Midazolam for Suicidal ER Patients
New York State Psychiatric Institute
Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion
Dr. Marie Eve Sophie Bussiere-Cote
Ketamine Versus Electroconvulsive Therapy in Depression
University of Ottawa
A Study of Human Multi-Sensory Integration
University of Pennsylvania
Ketamine vs Propofol for Sedation During Pediatric Bronchoscopy
Rabin Medical Center
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
University Hospital, Clermont-Ferrand
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients
Mayo Clinic
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Role Of Non-Specific Effects in The Treatment of Depression With Esketamine
Yale University
Ketamine for OUD and Suicidal Ideation in the ED
Brigham and Women's Hospital
Behavioural Activation Therapy and Esketamine for Resistant Depression
The Royal's Institute of Mental Health Research
Ketamine-assisted Therapy for Advanced GI Cancer
Brian Anderson, MD
Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) Trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers
University of Utah
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
GH Research Ireland Limited
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
University of Wisconsin, Madison
Phase 2 Clinical Trial of GH001 in Postpartum Depression
GH Research Ireland Limited
[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine
National Institute of Mental Health (NIMH)
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.